Form 4 for DGX Quest Diagnostics
Accepted 2026-07-29 17:04:48 ET · period of report 2026-07-28 · accession 0001022079-26-000087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-07-29 17:04 | 2026-07-28 | DGX | DELANEY MARK E | SVP, Chief Commercial Off | S - Sale | $235.18 | -1,600 | 10.3K | -13% | -$376.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-28 | S | D | 1,600 | $235.18 | 10,335 | D | — | — | (F1) This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |